Bahl & Gaynor’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,498
| Closed | -$1.24M | – | 334 |
|
|
2024
Q1 | $1.24M | Buy |
15,498
+64
| +0.4% | +$5.13K | 0.01% | 237 |
|
|
2023
Q4 | $1.69M | Buy |
15,434
+207
| +1% | +$22.7K | 0.01% | 218 |
|
|
2023
Q3 | $1.54M | Buy |
15,227
+12
| +0.1% | +$1.21K | 0.01% | 218 |
|
|
2023
Q2 | $2.07M | Sell |
15,215
-15
| -0.1% | -$2.04K | 0.01% | 208 |
|
|
2023
Q1 | $1.58M | Sell |
15,230
-11,984
| -44% | -$1.24M | 0.01% | 220 |
|
|
2022
Q4 | $2.41M | Sell |
27,214
-8,506
| -24% | -$754K | 0.02% | 193 |
|
|
2022
Q3 | $2.86M | Sell |
35,720
-12,482
| -26% | -$1M | 0.02% | 185 |
|
|
2022
Q2 | $4.62M | Buy |
48,202
+785
| +2% | +$75.2K | 0.03% | 165 |
|
|
2022
Q1 | $7.04M | Sell |
47,417
-1,383
| -3% | -$205K | 0.05% | 135 |
|
|
2021
Q4 | $6.92M | Buy |
48,800
+85
| +0.2% | +$12.1K | 0.04% | 151 |
|
|
2021
Q3 | $6.37M | Buy |
48,715
+147
| +0.3% | +$19.2K | 0.04% | 149 |
|
|
2021
Q2 | $6.68M | Sell |
48,568
-3,041
| -6% | -$418K | 0.04% | 143 |
|
|
2021
Q1 | $6.74M | Buy |
51,609
+1,281
| +3% | +$167K | 0.04% | 137 |
|
|
2020
Q4 | $5.64M | Buy |
50,328
+823
| +2% | +$92.2K | 0.04% | 139 |
|
|
2020
Q3 | $3.9M | Sell |
49,505
-1,320
| -3% | -$104K | 0.03% | 163 |
|
|
2020
Q2 | $3.66M | Buy |
50,825
+111
| +0.2% | +$7.99K | 0.03% | 162 |
|
|
2020
Q1 | $2.9M | Buy |
50,714
+13,892
| +38% | +$795K | 0.03% | 173 |
|
|
2019
Q4 | $4.12M | Buy |
36,822
+159
| +0.4% | +$17.8K | 0.03% | 160 |
|
|
2019
Q3 | $3.53M | Buy |
36,663
+8,111
| +28% | +$780K | 0.03% | 176 |
|
|
2019
Q2 | $2.44M | Buy |
+28,552
| New | +$2.44M | 0.02% | 208 |
|